Your browser doesn't support javascript.
loading
Rosuvastatin Does Not Affect Fasting Glucose, Insulin Resistance, or Adiponectin in Patients with Mild to Moderate Hypertension / 전남의대학술지
Chonnam Medical Journal ; : 31-37, 2013.
Artículo en Inglés | WPRIM | ID: wpr-788257
ABSTRACT
The effects of statins on insulin resistance and new-onset diabetes are unclear. The purpose of this study was to evaluate the effects of rosuvastatin on insulin resistance and adiponectin in patients with mild to moderate hypertension. In a randomized, prospective, single-blind study, 53 hypertensive patients were randomly assigned to the control group (n=26) or the rosuvastatin (20 mg once daily) group (n=27) during an 8-week treatment period. Both groups showed significant improvements in systolic blood pressure and flow-mediated dilation (FMD) after 8 weeks of treatment. Rosuvastatin treatment improved total cholesterol, low-density lipoprotein (LDL)-cholesterol, and triglyceride levels. The control and rosuvastatin treatment groups did not differ significantly in the change in HbA1c (3.0+/-10.1% vs. -1.3+/-12.7%; p=0.33), fasting glucose (-1.3+/-18.0% vs. 2.5+/-24.1%; p=0.69), or fasting insulin levels (5.2+/-70.5% vs. 22.6+/-133.2%; p=0.27) from baseline. Furthermore, the control and rosuvastatin treatment groups did not differ significantly in the change in the QUICKI insulin sensitivity index (mean change, 2.2+/-11.6% vs. 3.6+/-11.9%; p=0.64) or the HOMA index (11.6+/-94.9% vs. 32.4+/-176.7%; p=0.44). The plasma adiponectin level increased significantly in the rosuvastatin treatment group (p=0.046), but did not differ significantly from that in the control group (mean change, 23.2+/-28.4% vs. 23.1+/-27.6%; p=0.36). Eight weeks of rosuvastatin (20 mg) therapy resulted in no significant improvement or deterioration in fasting glucose levels, insulin resistance, or adiponectin levels in patients with mild to moderate hypertension.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Plasma / Pirimidinas / Sulfonamidas / Glucemia / Presión Sanguínea / Resistencia a la Insulina / Método Simple Ciego / Colesterol / Estudios Prospectivos / Ayuno Tipo de estudio: Ensayo Clínico Controlado / Estudio observacional Límite: Humanos Idioma: Inglés Revista: Chonnam Medical Journal Año: 2013 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Plasma / Pirimidinas / Sulfonamidas / Glucemia / Presión Sanguínea / Resistencia a la Insulina / Método Simple Ciego / Colesterol / Estudios Prospectivos / Ayuno Tipo de estudio: Ensayo Clínico Controlado / Estudio observacional Límite: Humanos Idioma: Inglés Revista: Chonnam Medical Journal Año: 2013 Tipo del documento: Artículo